Learn More
Invivogen R848 (Resiquimod), Dual TLR7/TLR8 Agonist, Lyophilized Powder, 1 mg

Supplier: Invivogen TLRLR8481

InvivoGen's R848 (Resiquimod) is a potent TLR7/TLR8 agonist, ideal for immunological research. Supplied as a lyophilized powder in two 500 µg vials, it activates immune cells, enhancing pro-inflammatory cytokine production. Its rigorous testing ensures no contamination with TLR2 or TLR4, making it a reliable tool for studying antiviral and antibacterial immunity, along with vaccine development.
The Fisher Scientific Encompass Program offers items which are not part of our distribution portfolio. These products typically do not have pictures or detailed descriptions. However, we are committed to improving your shopping experience. Please use the form below to provide feedback related to the content on this product.